Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
Biorce’s Aika represents a groundbreaking AI-driven clinical intelligence platform that enhances every phase of the clinical trial lifecycle by transforming slow, manual processes for protocol development and feasibility assessments into efficient, evidence-based automation. Leveraging insights from approximately one million real-world trials, Aika can swiftly produce first-draft study protocols, comprehensive regulatory documentation, site feasibility evaluations, risk management strategies, and other critical trial components significantly faster than conventional approaches, which helps in minimizing delays and expensive modifications. Aika not only ensures complete transparency in its recommendation processes, allowing teams to confidently communicate their decisions to regulators while retaining expert oversight, but also effectively combines the rapid capabilities of AI with the depth of clinical knowledge. By drastically reducing trial preparation times from weeks to mere days, it significantly decreases the chances of amendments and mitigates overall risk, all while seamlessly fitting into existing workflows without the need for extensive retraining. With Aika, clinical trial teams can focus more on strategic decision-making rather than being bogged down by administrative tasks.
Description
Cytel stands out as a prominent global innovator in software for clinical trial design, biometrics, and advanced analytics, focusing on maximizing the efficiency of clinical trials while aiding pharmaceutical companies in harnessing the full scope of both clinical and real-world data. Established in 1987 by renowned statisticians Cyrus Mehta and Nitin Patel, Cytel has consistently been a leader in adaptive clinical trial technology and the field of biostatistics. Its software solutions, notably the East Horizon platform, facilitate accurate trial design and simulation, employing adaptive and Bayesian methodologies to enhance protocols and expedite the drug development process. The East Horizon platform serves as a comprehensive integration of Cytel's reliable software offerings, featuring R integration that significantly improves trial design functions. Furthermore, Cytel provides the Xact software suite, which is an all-encompassing toolkit designed for statistical analysis of small datasets, including those with sparse and missing data. By continuously innovating and expanding its product offerings, Cytel remains committed to providing cutting-edge solutions that meet the evolving needs of clinical research.
API Access
Has API
No
API Access
Has API
No
Integrations
R
No
Pricing Details
No price information available.
Free Trial
Yes
Free Version
No
Pricing Details
No price information available.
Free Trial
Yes
Free Version
No
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Customer Support
Business Hours
No
Live Rep (24/7)
No
Online Support
Yes
Customer Support
Business Hours
Yes
Live Rep (24/7)
No
Online Support
Yes
Types of Training
Training Docs
Yes
Webinars
No
Live Training (Online)
Yes
In Person
No
Types of Training
Training Docs
Yes
Webinars
Yes
Live Training (Online)
Yes
In Person
Yes
Vendor Details
Company Name
Biorce
Founded
2024
Country
Spain
Website
www.biorce.com/our-software
Vendor Details
Company Name
Cytel
Founded
1987
Country
United States
Website
cytel.com
Product Features
Clinical Trial Management
21 CFR Part 11 Compliance
No
Document Management
No
Electronic Data Capture
No
Enrollment Management
No
HIPAA Compliant
No
Monitoring
No
Patient Database
No
Recruiting Management
No
Scheduling
No
Study Planning
No
Product Features
Clinical Trial Management
21 CFR Part 11 Compliance
No
Document Management
No
Electronic Data Capture
No
Enrollment Management
No
HIPAA Compliant
No
Monitoring
No
Patient Database
No
Recruiting Management
No
Scheduling
No
Study Planning
No